Lineage Cell Therapeutics, Inc. (LCTX)
1.22
+0.01
(+0.83%)
USD |
NYAM |
Jun 09, 16:00
1.225
0.00 (0.00%)
After-Hours: 20:00
Lineage Cell Therapeutics EPS Diluted (TTM) : -0.2873 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Curis, Inc. | -1.194 |
| Halozyme Therapeutics, Inc. | 2.780 |
| Agenus, Inc. | 1.670 |
| Amgen, Inc. | 14.38 |
| BioCryst Pharmaceuticals, Inc. | -1.776 |